Market Cap: $3.33M
BI
bioAffinity Technologies, Inc.
BIAF
NASDAQ (NASDAQ Capital Market)USD
Market Cap: $3.33M
Filed a patent for "compositions and methods for use in flow cytometry" on Thu, September 12, 2024
New US PatentFiled a patent for "porphyrin compounds and compositions useful for treating cancer" on Thu, September 28, 2023
New US PatentFiled a patent for "sputum analysis by flow cytometry; an effective platform to analyze the lung environment" on Fri, July 1, 2022
New US PatentFiled a patent for "detection of early-stage lung cancer in sputum using automated flow cytometry and machine learning" on Wed, July 20, 2022
New US Patent